URELLE
RxNorm 1048336· HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE· ORAL
Viatris Specialty LLC
Indications and usage
INDICATIONS and USAGE: Urelle ® is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.
Dosage and administration
DOSAGE and ADMINISTRATION: Adults – One tablet orally 4 times per day followed by liberal fluid intake. Pediatric – Dosage must be individualized by a physician for older children. Urelle® is not recommended for use in children 6 years of age or younger.
Warnings
WARNINGS: If rapid pulse, dizziness, or blurring of vision occurs, discontinue use immediately. Patients should be advised that urine will be colored blue when taking this medication. Do not exceed recommended dosage.
Contraindications
CONTRAINDICATIONS: Hypersensitivity to any of the ingredients is possible. Risk - benefit should be carefully considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- off label use13
- fatigue9
- vision blurred9
- cystitis interstitial8
- tremor7
- dizziness6
- pain6
- product use issue6
- vomiting6
- amnesia5
- asthenia5
- heart rate increased5
- maculopathy5
- nausea5
- staphylococcal infection5
- anxiety4
Adverse reactions (label)
To report SUSPECTED ADVERSE REACTIONS, contact Meda Pharmaceuticals Inc. at 1-877-999-8402 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
KR · 한국Products in Korea (12)
- 히노민정(황산히오스시아민)(주)드림파마
- 히노민정(황산히오스시아민)(주)드림파마
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 살프메칠렌블루주사1%(주)삼오제약
- 엔터팜메칠렌블루주사1%(주)엔터팜
- 디비팜메칠렌블루주사1%(주)한국디비팜
- 바라돈정(황산히요스시아민)위더스제약(주)
- 제이텍메칠렌블루주사1%제이텍바이오젠
- 메칠렌블루주사1%제이텍바이오젠
- 메칠렌블루주사1%제이텍바이오젠
View more: Full FDA label on DailyMed →Label effective 20150113